search
Back to results

Home Care Medication Management Program for the Frail Elderly

Primary Purpose

Chronic Illness, Cognitive Impairment

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
MD2 machine and nurse care coordination
Medplanner and Nurse Care Coordination
Sponsored by
Arizona State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Chronic Illness focused on measuring Home health care, Medication Management, Cognitive impairment, Medication adherence, Older adults, Care Coordination management

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 60 and older
  • Medicare Primary Payer
  • Impaired Medication Management ability as indicated by a score of 1 or higher on OASIS discharge assessment item M0780
  • Impaired Cognitive Functioning but able to follow directions with prompting as indicated by a score of 1 or 2 on OASIS discharge assessment item M0560
  • working telephone line
  • Discharge from home health care

Exclusion Criteria:

  • Not English speaking
  • Terminal diagnosis or hospice care
  • Use of other device for medications
  • Medicare via managed care
  • Use of private home care agency for medication management

Sites / Locations

  • University of Wisconsin-Milwaukee

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

Machine and NCC

Medplanner and NCC

Usual Care Group

Arm Description

Medications dispensed to subject via MD2 machine and nurse care coordination used to coordinate care among providers and fill machine at least every 2 weeks.

Medications loaded in medplanner by nurse care coordinator who coordinates care among providers and visits subject at least every 2 weeks

Admitted post home health care with no intervention.

Outcomes

Primary Outcome Measures

Geriatric Depression Scale
The Geriatric Depression Scale (GDS) was developed to identify depression in older adults. The original GDS was 30 questions, however, fifteen- and five-question versions also exist. When tested on the oldest old in the community, the 15-item scale was demonstrated to have favorable reliability and validity results. Impaired cognitive function (MMSE < 28) reduced the tool's specificity, but sensitivity was not affected by lower MMSE scores. The tool is scored into depression categories of "none/mild", "moderate" and "major".
Physical Performance Test (PPT)
This functional status test has demonstrated reliability and validity, is easy to administer, can be performed in a reasonable period of time, and imposes little burden on the individual being tested. Even men and women with mild to moderate dementia are capable of understanding the test and performing activities reliably. There are 7 items on the test that range in difficulty from very easy to perform (writing a sentence) to challenging (picking up a penny), thus encompassing a spectrum of physical capabilities.
SF-36 Health Survey
This tool is a widely used generic health status questionnaire measuring eight dimensions of health status: physical functioning, role limitations due to physical health problems, bodily pain, social functioning, general mental health, role limitations due to emotional problems, vitality, and general health perceptions. In addition, the SF-36 can be transformed into a Health State Utility Index that allows for health improvements to be stated in terms of quality adjusted life years (QALYs) gained.
Mental Mental Status Exam (MMSE)
This 11-item measure screens for cognitive abilities in the domains of orientation, memory, attention, recall, language and visual/spatial orientation. The MMSE may be a categorical or continuous-level variable. When used as a categorical variable, the MMSE is broken down into 4 levels: (a) score range 24-30 is considered within normal limits (WNL), (b) score range of 18-23 is considered mild cognitive impairment, (c) score range of 12-17 is considered moderate cognitive impairment, and (d) a score range of 11 or less is considered to be severe cognitive impairment.
Hospitalization
Medicare claims data will be the source of information for this measure.
Hospital Days
Medicare claims data will be the source of information for this measure.
Emergency Department Visits
Medicare claims data will be the source of information for this measure.
Medicare Costs
Medicare claims data will be the source of information for this measure.

Secondary Outcome Measures

Full Information

First Posted
March 15, 2011
Last Updated
January 4, 2012
Sponsor
Arizona State University
Collaborators
University of Wisconsin, Milwaukee, National Institute of Nursing Research (NINR)
search

1. Study Identification

Unique Protocol Identification Number
NCT01321853
Brief Title
Home Care Medication Management Program for the Frail Elderly
Official Title
Home Care Medication Management Program for the Frail Elderly
Study Type
Interventional

2. Study Status

Record Verification Date
January 2012
Overall Recruitment Status
Completed
Study Start Date
May 2006 (undefined)
Primary Completion Date
May 2010 (Actual)
Study Completion Date
May 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Arizona State University
Collaborators
University of Wisconsin, Milwaukee, National Institute of Nursing Research (NINR)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether a home care medication management program which includes nurse coordination and use of the MD.2 medication-dispensing machine will affect older adults' health outcomes, satisfaction, use of health care services, and health care costs over a one year period. The investigators propose a longitudinal three group repeated measures design, enrolling, and randomly assigning, clients who are discharged from a home health care agency with documented problems in medication management. One group will receive the MD.2 medication dispensing device and nurse coordination, the second group will receive a Medplanner: a simple box that has separate compartments for individual medication times over the course of a week plus nurse coordination, and the final group will receive Usual Care. The study hypotheses are the following: H1: With respect to health status outcomes, the MD.2 group will exhibit a more positive trajectory in physical and mental health status, functional status, cognitive status and depressive symptoms over the course of a year than will the Medplanner Group. H2: With respect to health status outcomes, the Medplanner Group will exhibit a more positive trajectory in physical and mental health status, functional status, cognitive status and depressive symptoms over the course of a year than will the Usual Care Group. H3: The rate of hospitalization, hospital days and emergency department visits will be significantly lower for the MD.2 Group as compared to the Medplanner Group. H4: The rate of hospitalization, hospital days and emergency department visits will be significantly lower for the Medplanner Group as compared to the Usual Care Group. H5: The nursing home admission rate will be significantly lower for the MD.2 Group as compared to the Medplanner Group. H6: The nursing home admission rate will be significantly lower for the Medplanner Group as compared to the Usual Care Group. H7: The total cost of care will be significantly lower for the MD.2 Group as compared to the Medplanner Group. H8: The total cost of care will be significantly lower for the Medplanner Group as compared to The Usual Care Group. H9: There will be incremental savings in terms of costs per quality adjusted life year (QALY) gained in the MD.2 group compared with the Medplanner Group. H10: There will be incremental savings in terms of costs per QALY gained in the Medplanner group compared with the Usual Care Group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Illness, Cognitive Impairment
Keywords
Home health care, Medication Management, Cognitive impairment, Medication adherence, Older adults, Care Coordination management

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
414 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Machine and NCC
Arm Type
Experimental
Arm Description
Medications dispensed to subject via MD2 machine and nurse care coordination used to coordinate care among providers and fill machine at least every 2 weeks.
Arm Title
Medplanner and NCC
Arm Type
Experimental
Arm Description
Medications loaded in medplanner by nurse care coordinator who coordinates care among providers and visits subject at least every 2 weeks
Arm Title
Usual Care Group
Arm Type
No Intervention
Arm Description
Admitted post home health care with no intervention.
Intervention Type
Other
Intervention Name(s)
MD2 machine and nurse care coordination
Intervention Description
MD2 machine filled at least every 2 weeks and subjects monitored for changes in condition. Additional visits made as needed. Care is coordinated with other providers such as the primary care physician and pharmacist.
Intervention Type
Other
Intervention Name(s)
Medplanner and Nurse Care Coordination
Intervention Description
Medications are dispensed via a medplanner filled by a nurse at least every 2 weeks and subjects monitored for changes in condition. Additional visits made as needed. Care is coordinated with other providers such as the primary care physician and pharmacist.
Primary Outcome Measure Information:
Title
Geriatric Depression Scale
Description
The Geriatric Depression Scale (GDS) was developed to identify depression in older adults. The original GDS was 30 questions, however, fifteen- and five-question versions also exist. When tested on the oldest old in the community, the 15-item scale was demonstrated to have favorable reliability and validity results. Impaired cognitive function (MMSE < 28) reduced the tool's specificity, but sensitivity was not affected by lower MMSE scores. The tool is scored into depression categories of "none/mild", "moderate" and "major".
Time Frame
12 months
Title
Physical Performance Test (PPT)
Description
This functional status test has demonstrated reliability and validity, is easy to administer, can be performed in a reasonable period of time, and imposes little burden on the individual being tested. Even men and women with mild to moderate dementia are capable of understanding the test and performing activities reliably. There are 7 items on the test that range in difficulty from very easy to perform (writing a sentence) to challenging (picking up a penny), thus encompassing a spectrum of physical capabilities.
Time Frame
12 months
Title
SF-36 Health Survey
Description
This tool is a widely used generic health status questionnaire measuring eight dimensions of health status: physical functioning, role limitations due to physical health problems, bodily pain, social functioning, general mental health, role limitations due to emotional problems, vitality, and general health perceptions. In addition, the SF-36 can be transformed into a Health State Utility Index that allows for health improvements to be stated in terms of quality adjusted life years (QALYs) gained.
Time Frame
12 months
Title
Mental Mental Status Exam (MMSE)
Description
This 11-item measure screens for cognitive abilities in the domains of orientation, memory, attention, recall, language and visual/spatial orientation. The MMSE may be a categorical or continuous-level variable. When used as a categorical variable, the MMSE is broken down into 4 levels: (a) score range 24-30 is considered within normal limits (WNL), (b) score range of 18-23 is considered mild cognitive impairment, (c) score range of 12-17 is considered moderate cognitive impairment, and (d) a score range of 11 or less is considered to be severe cognitive impairment.
Time Frame
12 months
Title
Hospitalization
Description
Medicare claims data will be the source of information for this measure.
Time Frame
12 month enrollment period
Title
Hospital Days
Description
Medicare claims data will be the source of information for this measure.
Time Frame
12 Month Enrollment Period
Title
Emergency Department Visits
Description
Medicare claims data will be the source of information for this measure.
Time Frame
12 month Enrollment Period
Title
Medicare Costs
Description
Medicare claims data will be the source of information for this measure.
Time Frame
12 Month Enrollment Period

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 60 and older Medicare Primary Payer Impaired Medication Management ability as indicated by a score of 1 or higher on OASIS discharge assessment item M0780 Impaired Cognitive Functioning but able to follow directions with prompting as indicated by a score of 1 or 2 on OASIS discharge assessment item M0560 working telephone line Discharge from home health care Exclusion Criteria: Not English speaking Terminal diagnosis or hospice care Use of other device for medications Medicare via managed care Use of private home care agency for medication management
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karen S Marek, PhD
Organizational Affiliation
Arizona State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Wisconsin-Milwaukee
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53201
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
23817284
Citation
Marek KD, Stetzer F, Ryan PA, Bub LD, Adams SJ, Schlidt A, Lancaster R, O'Brien AM. Nurse care coordination and technology effects on health status of frail older adults via enhanced self-management of medication: randomized clinical trial to test efficacy. Nurs Res. 2013 Jul-Aug;62(4):269-78. doi: 10.1097/NNR.0b013e318298aa55.
Results Reference
derived

Learn more about this trial

Home Care Medication Management Program for the Frail Elderly

We'll reach out to this number within 24 hrs